MedTrace Logo

Overall Survival and Disease-free Survival in Breast Cancer Patients Under COS

NCT02745262 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2016-04-20

No results posted yet for this study

Summary

The main objective of the study is to evaluate the overall survival and disease-free survival in breast cancer patients under 40 years old. They underwent controlled ovarian stimulation (COS) for fertility preservation versus women of the same age, type and stage of breast cancer, who have not been subjected to COS.

Conditions

Interventions

OTHER

Collect retrospectively the follow-up data

Collect retrospectively the follow-up data. Each patient is called in order to request data authorization, to complete and track information.

Sponsors & Collaborators

  • IVI Vigo

    lead OTHER

Principal Investigators

  • Elkin Muñoz · IVI Vigo

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-03-31
Completion
2018-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745262 on ClinicalTrials.gov